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Abstract: Multicellular organisms comprise a variety of cell types that have the same genotype but distinct phenotypes. This diversity
is possible because of the establishment of a specific epigenetic landscape that stabilizes gene expression profiles that are exclusive for a
particular cell type. Accumulating data indicate that the maintenance, loss, and reacquisition of pluripotency are dynamically regulated
by epigenetic alterations evoked by a subset of cellular factors. A better understanding of the epigenetic mechanisms involved in stem
cell biology and differentiation will improve our ability to use these cells in the clinical context. Here we review current insights into the
epigenetic mechanisms implicated in embryonic development and the induction of pluripotency.
Key words: Epigenetics, chromatin modifications, DNA methylation, noncoding RNAs, pluripotent stem cells, differentiation,
reprogramming

1. Introduction
Organisms at the multicellular level are composed of
various cell types. Although they harbor similar genomes,
the cells differ dramatically in terms of their morphology,
physiology, and functions. During development, initially
totipotent cells proliferate intensively, acquire more
specialized phenotypes, and progressively lose their
differentiation capacity. These changes are possible
due to profound alterations in their gene expression
profiles that are evoked and stabilized mainly through
epigenetic means. Multifaceted epigenetic regulation
comprises complex, interconnected protein networks
that affect DNA methylation, posttranslational histone
modifications, histone variant composition within
nucleosomes, higher-order chromatin arrangement, and
noncoding RNA expression (Li et al., 2012; Apostolou
and Hochedlinger, 2013). Deregulation of the epigenetic
machinery may lead to the loss of self-renewal capacity
and abnormal differentiation, which ultimately may
induce developmental aberrancies.
Pluripotency is a transient state in vivo. Thus, many of
the reported studies in this field utilized cultured in vitro
embryonic stem cells (ESCs) derived from the inner cell
mass of blastocysts. Cell lines that are obtained in this
manner maintain their potential to differentiate into the
three germ layers and proliferate virtually indefinitely.
* Correspondence: u.oleksiewicz@gmail.com
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Recently, converting somatic cells into so-called induced
pluripotent stem cells (iPSCs) was shown to be possible
through the forced expression of pluripotency genes
(Takahashi and Yamanaka, 2006) or chemical induction
(Hou et al., 2013). This conversion is driven by a profound
epigenetic reprogramming that enables the reacquisition
of the chromatin state characteristic of ESCs (Maherali et
al., 2007; Mikkelsen et al., 2008; Mattout et al., 2011).
Due to their multilineage differentiation potential,
pluripotent stem cells constitute an attractive source of
biological material with wide applicability in regenerative
medicine, disease modeling, and drug cytotoxicity testing.
Thus, a better understanding of the epigenetic regulation of
pluripotency is essential to improve our capacity to control
and manipulate these cells and their reprogramming
procedures in a clinical setting. Many epigenetic modifiers
and mechanisms have been shown to play critical roles in
the maintenance and reacquisition of pluripotency. Here
we focus on the current state of knowledge related to the
epigenetic processes implicated in stem cell biology.
2. An overview on the epigenetic mechanisms in the
regulation of pluripotency
Pluripotent stem cells possess a distinctive permissive
chromatin structure that facilitates the dynamic transition
into more differentiated cell types. In the pluripotent

GŁADYCH et al. / Turk J Biol
state, the chromatin maintains a homogeneously
dispersed structure with a high contribution of loose
euchromatin and low dosage of heterochromatin. Upon
lineage commitment, this ratio changes as the chromatin
acquires inactivating markers and becomes heterogeneous
with distinctive condensed loci (Ahmed et al., 2010).
Open chromatin architecture facilitates in pluripotent
stem cells transcriptional hyperactivity, allowing for the
high abundance of the genes involved in transcription
and epigenetic remodeling, and also in the activation of
noncoding transcripts and retroelements (Efroni et al.,
2008). This feature contributes to the plasticity of the cells
to undergo a differentiation program towards any of the
three germ layers.
An open chromatin structure is maintained by
chromatin remodelers that actively relax compacted
regions and/or affect nucleosome composition,
structure, and posttranslational modification of histones.
Modifications of the histone residues may alter their
physical contact with DNA or with epigenetic modifiers
that remodel the chromatin within a given region. In
pluripotent cells, histones are frequently acetylated, which
removes their negative charge and limits interaction with
DNA. In addition, methylation at lysines 4, 36, and 79
of histone 3 facilitate loose chromatin conformation and
allow gene transcription: H3K4me3 is enriched at the
active gene promoters, while H3K36me3 and HK79me3
are enriched at the gene bodies (Gaspar-Maia et al., 2011;
Liang and Zhang, 2013). In contrast, repressed genes are
marked with H3K27me3. In pluripotent stem cells, certain
differentiation-related genes are localized into bivalent
domains containing both active (H3K4me3) and repressive
(H3K27me3) markers. A high level of bivalent regions,
which are transcriptionally inactive, is characteristic
to pluripotency. This so-called poised regions may be
switched either to an active or a repressed state through the
removal of one of the markers, permitting a fast response
to developmental cues (Bernstein et al., 2006; Mikkelsen et
al., 2007; Adamo et al., 2011). Another repressive marker,
H3K9me3, is enriched in stem cells at the infrequent
heterochromatin regions within repetitive and imprinted
loci. Furthermore, promoters and enhancers associated
with pluripotency have a low DNA methylation level that
permits transcriptional activation, while repressive DNA
hypermethylation is found alongside H3K9me3 within
repetitive and imprinted regions (Mikkelsen et al., 2007;
Mikkelsen et al., 2008; Polo et al., 2012).
Changes in the cellular potency are associated with
the massive turnover of chromatin modifiers followed
by alterations in the epigenetic signature of the cell.
Differentiation increases H3K27me3 and H3K9me3
deposition to suppress the pluripotency genes and the
genes specific to other tissue types (Mikkelsen et al., 2007).

Moreover, differentiation is accompanied by change in
DNA methylation profile, whereby pluripotency-associated
promoters and enhancers become hypermethylated to
ensure stable silencing of their expression (Mohn et al.,
2008; Polo et al., 2012). The process involves multiple
epigenetic modifiers that mediate DNA methylation
changes, histone deacetylation, and trimethylation of
H3K27 and H3K9. Lack of those modifiers may lead to
sustained pluripotency and impaired differentiation. In
contrast, somatic cell reprogramming to iPSCs requires
reacquisition of the open chromatin conformation
and reestablishment of the pluripotency-specific DNA
methylation pattern. Thus, the epigenetic modifiers that
drive euchromatization facilitate dedifferentiation, while
the heterochromatin factors block the process (Liang
and Zhang, 2013). Although the general mechanisms
maintaining pluripotency and driving reprogramming
and differentiation are relatively well understood, the
exact kinetics of the changes and the set of the epigenetic
players responsible for these phenomena remain largely
unexplored. Improving the understanding of the epigenetic
enzymes and substrates, as well as the timing of required
alterations, will greatly contribute to our knowledge about
these processes. This knowledge is urgently needed to
improve culture, reprogramming, and differentiation
protocols that will allow precise control and manipulation
of various cell types required for regenerative medicine and
establishment of in vitro disease models. In this review, we
provide a summary of the current understanding of the
epigenetic factors involved in reprogramming, stem cell
maintenance, and differentiation.
3. Higher chromatin architecture
3.1. Three-dimensional chromatin arrangement
The global chromatin arrangement plays an important role
in transcriptional regulation by providing 3D interactions
between gene promoters and other regulatory sites (e.g.,
enhancers) (Kagey et al., 2010). Pluripotent stem cells have
a unique three-dimensional chromatin structure. Electron
microscopy imaging has shown that their chromatin
possesses a homogeneously dispersed architecture,
with long ranges of euchromatin and a low amount of
condensed foci at the nuclear envelope regions. This
spatial arrangement is established by the eight-cell stage
of embryonic development, whereas highly condensed
chromatin domains reappear upon lineage commitment
(Ahmed et al., 2010). Consistently, active chromatin
modifications are frequent, while repressive marks are less
common in ESCs compared with the more specialized cell
types (Hawkins et al., 2010; Mattout et al., 2011).
It was shown that pluripotency-specific genes are
involved in the maintenance of diffused chromatin
structure. For example, deletion of Oct4 resulted in
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chromatin compaction in ESCs (Ahmed et al., 2010).
Additional studies indicated that the core pluripotency
factors (Oct4, Nanog, and Sox2) create an interacting
network between their binding sites, thereby affecting
chromatin folding in ESCs (de Wit et al., 2013). The
expression of pluripotency factors also relies on adequate
chromatin organization. Klf4 was shown to recruit looping
factors, cohesins, to the Oct4 distal enhancer, thereby
promoting the expression of endogenous Oct4 during
reprogramming to iPSCs (Wei et al., 2013). Similarly, DNA
fragments interacting with the Nanog promoter in ESCs
and iPSCs are frequently bound by DNA looping factors
and genes from the pluripotency network (Esrrb, Klf4, and
Sox2), thereby enhancing Nanog expression (Apostolou et
al., 2013).
3.2. Nucleosome composition
The local chromatin structure is largely dependent on
the nucleosome composition, density, and positioning.
Histone variants assembled within nucleosomes differ in
their susceptibility to posttranslational modifications and
in the turnover rate that influences nucleosome stability
(Skene and Henikoff, 2013). The dynamic exchange of
histones is important for the maintenance of stem cell
identity. Knockout of the nucleosome assembly factor
HirA results in accelerated differentiation, probably due
to the accumulation of unbound histones H3 and H3.3.
In contrast, increased binding of mutated H1 to DNA
arrests the differentiation potential of ESCs (Meshorer et
al., 2006).
The expression of histone variants is specific to a
particular cell type. Recent reports provided evidence that
different histone isoforms play a major role in the acquisition
and maintenance of pluripotency. Variants expressed
at high levels in oocytes, testes, and zygotes (TH2A and
TH2B) augment reprogramming of somatic cells into
iPSCs (Shinagawa et al., 2014). Conversely, the isoform
macro-H2A, elevated upon differentiation, constitutes a
barrier to reprogramming and needs to be removed from
the nucleus of oocytes upon somatic cell nuclear transfer
(Pasque et al., 2012). In differentiating cells, this isoform
was shown to contribute to the H3K27me3-mediated
silencing of the genes implicated in pluripotency and
development (Barrero et al., 2013). Moreover, knockout
of macro-H2A enhances OSKM-driven reprogramming
to iPSCs. Another isoform (H2A.Z) implicated in
nucleosome plasticity becomes elevated in pluripotent
stem cells (Gaspar-Maia et al., 2013). In ESCs, H2A.Z
localizes with the H3K27me3 modification not only to the
promoters and distal elements, as observed in somatic cells,
but also to the intergenic regions. This broad deposition
suggests that H2A.Z may promote nucleosome exchange
in pluripotent cell, thereby rendering the chromatin
refractory to H3K27me3-mediated condensation (Zhu
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et al., 2013). Additionally, recent studies have shown that
the isoform H3.3, which is incorporated into both active
and repressed chromatin in ESCs, localizes to class I and
II endogenous retroviruses together with H3K9me3 and
TRIM28 to participate in the silencing of these parasitic
sequences (Elsasser et al., 2015). This observation suggests
that in addition to their nucleosome remodeling function,
histone variants may have more subtle and targeted roles
in pluripotent stem cells.
3.3. ATP-dependent chromatin modifiers
In addition to histone variants, ATP-dependent chromatin
modifiers are involved in the local chromatin arrangement.
These large remodeling protein complexes chaperone
histone variant exchange and catalyze the removal or
repositioning of nucleosomes (Swygert and Peterson,
2014). In pluripotent stem cells, the SWI/SNF complex
(comprising Brg1, Baf155, and Brm proteins) is responsible
for chromatin decondensation through interaction with
Oct4 (Singhal et al., 2010). For this reason, high expression
of the Baf subunits (esBaf, Baf155, and Brg1) improves the
efficiency of iPSC generation (Singhal et al., 2010; Kleger
et al., 2012). Another chromatin modifying factor (Ino80)
colocalizes with the core pluripotency genes (Oct4, Nanog,
and Sox2) and maintains an open chromatin structure to
facilitate the upregulation of the pluripotency network.
Loss of Ino80 induces differentiation of ESCs, hinders
reprogramming, and impairs blastocyst development
(Wang et al., 2014). Additionally, Tip60-p400 from the
Ino80 family, which is responsible for histone acetylation,
was demonstrated to guard the self-renewal properties of
ESCs (Fazzio et al., 2008).
The Chd factors are other chromatin remodeling
proteins involved in stem cell functions. Chd1 is essential
for the maintenance of an open chromatin structure
in ESCs. Its depletion results in heterochromatization
and differentiation towards neural lineages. Moreover,
Chd1 knockdown impairs the efficiency of iPSC colony
formation (Gaspar-Maia et al., 2009). Two other members
of the Chd family (Chd3/Mi2α and Chd4/Mi2β) are
components of the NuRD complex. This complex contains
histone deacetylases: HDAC1 and 2 and the methyl-CpG
binding domain proteins (Mbd2/3), which together drive
the repression of a target locus. Through interaction with
other chromatin remodeling proteins (e.g., Lsd1, esBaf,
Prc2, Oct4, and Tet1) (Yildirim et al., 2011; Latos et al.,
2012; Reynolds et al., 2012; Whyte et al., 2012), NuRD
seems to play a fine-tuning role between pluripotency and
differentiation. It has been proposed that the repressive
NuRD complex associates with the activating esBaf at
the promoters of a number of pluripotency genes to
antagonistically regulate their expression (Yildirim et al.,
2011), thus mediating lineage commitment (Reynolds
et al., 2012). This effect is additionally strengthened by
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the NuRD-interacting protein Lsd1, which facilitates
the demethylation of H3K4me3 at pluripotency-specific
enhancers (Whyte et al., 2012). This result is in accordance
with the observations published by Kaji et al. (2006),
who demonstrated that ESCs devoid of Mbd3/NuRD
exhibited impaired differentiation potential and sustained
self-renewal properties independent of LIF signaling.
In contrast, the inhibition of the NuRD proteins (Hdac
and Mbd2/3) via small molecules or RNAi facilitates the
reacquisition of an open chromatin architecture during
reprogramming, thereby improving the efficiency of iPSC
generation (Huangfu et al., 2008; Hou et al., 2013; Lee et
al., 2013; Luo et al., 2013) even to 100%, as was shown in
Mbd3 depletion studies (Rais et al., 2013). However, loss
of the Mbd3/NuRD complex was also shown to impair the
generation of naïve pluripotent stem cells (dos Santos et
al., 2014), which indicates that Mbd3 function may vary
depending on the cellular context and developmental
stage.

3.4. Histone modification
Posttranslational histone modifications affect physical
interactions between histones and DNA or other chromatin
factors (Figure 1). The transition between a permissive
and a repressive chromatin environment is stringently
regulated by the histone acetylation process (Eberharter
and Becker, 2002). The positive charge of lysine residues
on histones is neutralized by the addition of an acetyl
group; hence, interaction with negatively charged DNA
becomes weaker, which leads to local euchromatization
(Kingston and Narlikar, 1999). Usually, histone acetylation
is associated with activation of gene transcription, whereas
deacetylation is associated with repression (Shang et
al., 2000). Apart from the global effect of acetylation
on chromatin structure, posttranslational histone
modifications (Figure 2), including both acetylation and
methylation, play a role as docking sites for other proteins.
These chemical modifications may facilitate or impede
histone interaction with other factors (so-called readers)

PLURIPOTENCY-RELATED GENES
Pluripotent cells
Ac

M

Ac

M

Somatic cells
M M

M

M

Ac Histone acetylation
M

H3K4me3

M H3K9me3
M

H3K27me3
Unmethylated cytosine

Methylated cytosine
Figure 1. Chromatin reorganization within pluripotency-related genes. DNMTs: DNA methyltransferases; HATs: histone acetylases;
HDACs: histone deacetylases; HDMs: histone demethylases; HMTs: histone methyltransferases.
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Histone 3 modifications

KDM5B

JARID1
WDR5

LSD1

K4

EHMT2

DOT1L

K79

SUV39H1/2

K9

SETDB1

H3
ASH1L

K36
methylation

K27

SETD2

demethylation
– repressive histone modifications

PRC2
KDM2B

UTX

– active histone modifications
– histone demethylases
– histone methyltransferases
Figure 2. Schematic representation of H3 methylation modifications. Red indicates active and blues indicates repressive modifications.
Writers (methyltransferases) and erasers (demethylases) for each modification are also shown.

that drive the decondensation or condensation of a given
locus.
3.4.1. Histone acetylation
The histone acetylation profile is essential for adequate
functioning of stem cells. Acetylation decreases the
positive charge of histones, thus enabling acquisition and
maintenance of the open chromatin structure characteristic
for pluripotent cells (Kingston and Narlikar, 1999). Indeed,
somatic cell reprogramming to iPSCs is greatly enhanced
by the addition of HDAC inhibitors (e.g., valproic acid,
trichostatin A, butyrate). It was shown that inhibition of
HDACs can improve reprogramming efficiency even more
than 100-fold (Huangfu et al., 2008; Mali et al., 2010).
HDAC inhibition enhances the expression of pluripotency
factors, even without the addition of exogenous c-Myc or
Klf4 in the reprogramming cocktail (Mali et al., 2010).
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Most frequently, histone acetylation is associated with
actively transcribed genes. Xie et al. (2009) demonstrated
that in pluripotent stem cells H3K56Ac is deposited within
the active, pluripotency-associated genes and miRNAs
(Nanog, Sox2, Oct4, Lefty1, Dppa4, miR-302/367). Upon
differentiation, H3K56Ac deposition shifts towards
developmental genes. Nevertheless, in certain cases
H3K56Ac might also mark repressed loci.
Additionally, acetylated lysines may alter protein
binding sites, thus allowing for expanded protein
association. Many transcription factors and chromatin
modifiers contain a bromodomain, whose docking onto
chromatin may be dependent on the acetylation status
of chromatin (Yang, 2004). One such bromodomaincontaining protein is Atad2, which associates with
acetylated histones to maintain open chromatin and
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to support active transcription of neighboring genes.
Although loss of Atad2 has little effect on the self-renewal
properties of stem cells, it reduces the proliferative
potential of ESCs during differentiation and modulates
the timing and intensity of expression of differentiation
markers (Morozumi et al., 2015). Another protein with
a bromodomain, Brd4, is a histone chaperone that is
recruited by acetylated H4 to facilitate transcription. In
stem cells, Brd4 is crucial to maintain the expression of
Nanog and other pluripotency markers, while its inhibition
leads to the spontaneous onset of differentiation (Horne et
al., 2015; Gonzales-Cope et al., 2016).
3.4.2. H3K4 methylation
In human cells, the trimethylated histone H3 lysine 4
(H3K4me3) is deposited at both active and inactive
promoters. However, when associated with RNA PolII,
H3K4me3 marks actively transcribed genes. The presence
of H3K4me3 within inactive regions may be partially
explained by its frequent colocalization with the repressive
H3K27me3 mark within so-called bivalent domains
(Guenther et al., 2007). Although bivalent regions are
present in all cell types, they occur particularly frequently
in ESCs to maintain many differentiation-specific genes in
a poised state (Bernstein et al., 2006; Mikkelsen et al., 2007).
H3K4 methylation is deposited by several specific histone
methyltransferases from the trithorax group (TrxG) and is
removed by demethylases (e.g., Lsd1/Kdm1a and Jarid1/
Kdm5a) (Figure 2). Appropriate H3K4me turnover and
deposition is essential in developmental processes, and
many H3K4 methylation modifiers have been shown to
control self-renewal and lineage commitment (Gu and
Lee, 2013). The H3K4 mono- and dimethyltransferases
Mll4/Kmt2d bind to DNA in a pattern specific for a
given differentiation stage and cell type. During cellular
differentiation, Mll4 colocalizes with lineage-specific
transcription factors on the enhancers involved in
differentiation to contribute to their activation (Lee et al.,
2013). Expression of the Wdr5 protein, which is a main
subunit of the trithorax complex, was shown to be highly
specific to pluripotent stem cells. Wdr5 physically interacts
with Oct4, Nanog, and Sox2, which together cooperatively
upregulate key self-renewal genes. It is highly likely that
for this reason ESCs lacking Wdr5 lose their self-renewal
capacity, whereas downregulation of Wdr5 decreases the
generation of iPSC colonies (Ang et al., 2011).
Contrasting effects were observed in the case of the
Jarid1/Kdm5b demethylase. Jarid1/Kdm5b colocalizes with
H3K4me3 close to active gene promoters and enhancers
in ESCs. Upon differentiation, Kdm5b catalyzes H3K4me3
removal to inhibit the expression of pluripotency-specific
genes (Kidder et al., 2014). Another demethylase (Lsd1/
Kdm1a) fine-tunes the balance between the H3K4me3 and
H3K27me3 marks at bivalent regions of the developmental

gene promoters targeted by Oct4 and Nanog in human
ESCs. Adamo et al. (2011) demonstrated that the loss of
Lsd1/Kdm1a resulted in the progressive differentiation
of ESCs due to the accumulation of H3K4me3, which
disrupted the poised status of lineage-specific genes and
activated their expression.
3.4.3. H3K36 methylation
The H3K36me3 mark accumulates within the bodies of
active genes and facilitates their transcriptional elongation
(Mikkelsen et al., 2007). H3K36 methylation (Figure 2)
is catalyzed by the Ash1l and Setd2 enzymes, whereas
Kdm2b acts as a vitamin C-dependent H3K36me3
demethylase (Eram et al., 2015). The addition of vitamin
C to the reprogramming media facilitates Kdm2b-induced
H3K36me3 demethylation, thereby promoting iPSC
generation. Moreover, Kdm2b increases reprogramming
efficiency by suppression of the Ink4/Arf locus, thus
overcoming cell senescence (Wang et al., 2011). Liang et
al. (2012) also demonstrated that Kdm2b overexpression
augmented somatic cell reprogramming, especially during
its early phases. Kdm2b was shown to bind to the promoters
of the genes activated early in the reprogramming and
participate in their upregulation. The identified Kdm2baffected genes are known to be involved in adhesion,
morphology, epithelial phenotype, and pluripotency.
3.4.4. H3K79 methylation
Another marker of active chromatin deposited at
transcribed gene bodies is H3K79me3. Deletion of the Dot1l
gene, which serves as an H3K79 methyltransferase, leads
to severe developmental defects and embryonic lethality.
In in vitro culture, ESCs lacking Dot1l present reduced
levels of heterochromatin modifications at telomeres and
centromeres, which leads to aneuploidy, abnormal telomere
elongation, and, as a consequence, impaired proliferation
(Jones et al., 2008). Despite deleterious effects in ESCs,
Dot1l inhibition was shown to improve the efficiency of
reprogramming in the absence of Klf4 and c-Myc. Indeed,
the H3K79 methylation level decreases at genes involved
in the epithelial-to-mesenchymal transition during the
early stages of reprogramming. Therefore, the reduction
in Dot1l expression enables the demethylation of H3K79
from somatic genes, including the genes responsible
for the mesenchymal state. This facilitates epigenetic
silencing of these genes, promotes the mesenchymal-toepithelial transition, and accelerates the reacquisition of
pluripotency features (Onder et al., 2012).
3.4.5. H3K27 methylation
H3K27me3 is a histone modification that represses
gene expression in multiple contexts. Trimethylation
of H3K27 is mediated by the polycomb repressive
complex 2 (Prc2) that contains Ezh2, Suz12, and Eed,
whereas demethylation is catalyzed by Utx1 (Figure 2).
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The H3K27me3 modification plays an important role in
differentiation and dedifferentiation; however, it seems to
have a lower impact on the maintenance of the pluripotent
state (Pasini et al., 2007; Chamberlain et al., 2008; Marks
et al., 2012; van Heeringen et al., 2014). The global level of
H3K27me3 increases with the progress of differentiation:
it is reduced in ESCs cultured in the presence of the
Mek and Gsk3 inhibitors that force the cells into naïve
pluripotency state (Marks et al., 2012), and it rises after the
blastula stage (van Heeringen et al., 2014). Interestingly,
ESCs lacking Pcr2 subunits, Eed or Suz12, demonstrate
slightly elevated expression of Prc2 target developmental
genes, but they preserve their self-renewal properties
and can contribute to the three germ layers (Pasini et al.,
2007; Chamberlain et al., 2008). Nevertheless, chimeras
with Eed null cells show developmental postimplantation
defects (Chamberlain et al., 2008). Additionally, ESCs
devoid of Suz12 undergo improper differentiation that
manifests as the abnormal morphology of embryonic
bodies, retained expression of pluripotency genes, and
limited activation of differentiation markers (Pasini et al.,
2007). Appropriate H3K27me3 deposition is essential for
successful iPSC generation. Multiple studies reported that
knockdown of Ezh2, Suz12, and Eed subunits decreased
reprogramming efficiency (Pereira et al., 2010; Onder et
al., 2012; Ding et al., 2014). The H3K27me3 demethylase
Utx is also required for appropriate reprogramming. Loss
of Utx leads to a reduced number of iPSC colonies due
to aberrant retention of the H3K27me3 mark at the OSK
target genes, which prevents their activation (Mansour et
al., 2012).
3.4.6. H3K9 methylation
Pluripotent cells harbor low amounts of H3K9me3,
which is deposited mainly at the satellite, telomere,
and retroelement repeats to maintain a repressed
chromatin within these sequences (Mikkelsen et al.,
2007). Its global level rises during differentiation,
spreading along silenced regions and inducing cell typespecific heterochromatization (Wen et al., 2009). H3K9
methylation is catalyzed by the G9a/Ehmt2, Setdb1, and
Suv39h1/2 methyltransferases and is removed by a number
of demethylases, including Kdm3a, Kdm3b, Kdm4b, and
Kdm4c (Figure 2). An appropriate H3K9me3 distribution
is essential for the maintenance and reacquisition of
pluripotency. In pluripotent stem cells, Oct4 induces the
expression of the H3K9me2/3 demethylases Kdm3a and
Kdm4c, which in turn positively regulate the expression
of several other pluripotency factors by maintaining the
demethylated status of H3K9 within their promoters (Loh
et al., 2007). Conversely, the G9a/Ehmt2 methyltransferase
is upregulated at the early stages of differentiation to drive
the epigenetic inactivation of Oct4 and Nanog. Embryos
lacking G9a/Ehmt2 expression fail to downregulate the
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core pluripotency factors, ultimately leading to impaired
embryonic development and lethality (Yamamizu et al.,
2012). Other histone methyltransferases (i.e. Setdb1 and
Suv39h1/2) participate in the inhibition of retroelements
in ESCs. It is highly likely that H3K9me3-mediated
silencing prevents the potentially deleterious activation
of retroelements during the global rearrangement of
DNA methylation that occurs during the early stages of
development (Matsui et al., 2010; Bulut-Karslioglu et al.,
2014). Tight regulation of H3K9 modification was also
shown to be an important event during somatic cells’
dedifferentiation. The retention of H3K9me3 in cells
undergoing reprogramming blocks the transition from
the pre-iPSC to iPSC stage (Chen et al., 2013; Sridharan et
al., 2013). Reduced H3K9me3 and subsequent chromatin
decondensation obtained through the repression of the
H3K9 methyltransferases (G9a/Ehmt2, Suv39h1/2, and
Setdb1) enhances the formation of fully reprogrammed
iPSC colonies (Soufi et al., 2012; Sridharan et al., 2013).
In contrast, overexpression of the H3K9me3 demethylases
facilitates reprogramming via OSKM induction (Chen et
al., 2013) and somatic cell nuclear transfer (Matoba et al.,
2014).
4. DNA modifications
4.1. DNA methylation
DNA methylation and demethylation are essential
for mammalian development and adult homeostasis,
and thus these processes need to be strictly regulated.
DNA methylation is crucial for genome stability, X
chromosome inactivation, repression of retroelements,
and proper expression of imprinted genes (Messerschmidt
et al., 2014). In the human genome DNA methylation
predominantly occurs in a symmetrical CpG context. The
regions of increased CpG density, so-called CpG islands,
tend to be hypomethylated in contrast to hypermethylated
dispersed CpG sites. CpG islands are often located within
housekeeping gene promoters and genes involved in
development (Deaton and Bird, 2011). Most of the germ
cell-specific genes and pluripotency gene promoters
contain intermediate CpG density. Hypermethylation of
these promoters depends on lineage commitment and
results in gene expression silencing during differentiation
(Weber et al., 2007; Meissner et al., 2008).
Establishing the correct DNA methylation pattern is an
important event during the first few days of embryogenesis.
Upon fertilization, CpG methylation in the male pronucleus
is erased. Then, after zygote formation, both the maternal
and paternal DNA is progressively demethylated, and only
parent-of-origin-specific imprinted regions preserve their
methylation patterns during embryogenesis (Li, 2002).
Low DNA methylation levels are associated with the open
chromatin structure required for the transcriptional activity
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of the zygotic genes. After implantation, a specific DNA
methylation profile is reestablished in a lineage-specific
manner by de novo DNA methyltransferases (Dnmt3a
and Dnmt3b) and is maintained during subsequent cell
divisions by Dnmt1. The precision of DNA methylation is
critical for appropriate embryonic development because a
deficiency in any of the Dnmts causes postimplantation or
postnatal lethality (Li et al., 1992; Okano et al., 1999).
Defined methylation profiles are stable in normal
somatic cells throughout life. Active gene promoters
and enhancers are characterized by a low level of DNA
methylation in contrast to repressed pluripotency-related
genes (Figure 1), which tend to be hypermethylated (Polo
et al., 2012). Thus, reprogramming of somatic cells to
iPSCs requires massive changes in the DNA methylation
profile. The global level of DNA methylation is higher in
pluripotent cells compared to differentiated cells. In fact,
pluripotent and somatic cells can be distinguished based
on their DNA methylation signatures that include specific
sets of genes characteristic for a given cell type (Bock et al.,
2011). The demethylation of pluripotency-related genes
occurs late in reprogramming and is thought to be a ratelimiting step in this process. The DNA methylation levels
of Oct4 and Nanog promoters seem to be particularly
important for establishing the proper pluripotent
character of the obtained iPSCs (Takahashi and Yamanaka,
2006). Unsurprisingly, the efficiency of reprogramming
is increased by the addition of DNA methyltransferase
inhibitors (e.g., 5-azacytidine) (Mikkelsen et al., 2007;
Hou et al., 2013). Both the demethylation of pluripotencyrelated genes and the methylation of lineage-specific genes
seem to occur subsequent to histone modifications. This
may explain why pre-iPSC colonies are unstable and
require an adequate DNA methylation pattern to stabilize
pluripotency (Koche et al., 2011).
4.2. DNA demethylation
As mentioned in the previous section, the DNA
methylation pattern is reset during the early stages of
embryogenesis. Demethylation has been proposed to
proceed via active mechanisms utilizing Tet (ten-eleven
translocation) enzymes independent of DNA replication.
The Tet proteins belong to the family of dioxygenases that
catalyze the hydroxylation of 5mC (5-methylcytosine) to
5hmC (5-hydroxymethylcytosine) (Pastor et al., 2013).
Hydroxymethylated cytosine may be further modified to
an unmethylated form through the base excision repair
mechanism or DNA replication (Bagci and Fisher, 2013).
DNA in male gametes contains high levels of 5hmC. This
phenomenon is not observed after Tet3 knockdown,
suggesting the essential role of the enzyme in the
hydroxylation of 5mC (Iqbal et al., 2011). Interestingly,
the distribution of 5hmC was shown to be enriched at
the promoters within the bivalent chromatin marked by

H3K4me3 and H3K27me3. Thus, hydroxymethylation
contributes to transcriptional repression but protects DNA
from methylation and permanent inactivation (Pastor et
al., 2013).
Tet factors also participate in the epigenetic
reprogramming of iPSCs. The forced expression of OSKM
factors in mouse embryonic fibroblasts upregulates Tet2
expression, whereas Tet2-deficient fibroblasts are incapable
of forming iPSC colonies (Doege et al., 2012). Costa et
al. (2013) demonstrated that overexpression of Tet1 and
Tet2 augments reprogramming process, resulting in an
increased number of iPSC colonies. Furthermore, they
provided evidence that the interaction between Nanog and
Tet1 increases hydroxylation within the promoters of other
pluripotency-related genes, Oct4 and Esrrb, subsequently
resulting in their activation. Tet1 not only enhances
reprogramming by demethylating the Oct4 promoter, but
also may act as a reprogramming factor. It has been shown
that Tet1 can replace Oct4 in the reprogramming cocktail
with comparable efficiency (Gao et al., 2013).
4.3. Epigenetic memory
Although iPSCs are highly similar to ESCs from the
molecular, phenotypic, and functional points of view, iPSCs
may maintain some of the methylation pattern of their
cells of origin. This phenomenon (defined as epigenetic or
somatic memory) may impair the differentiation capacity
of iPSCs (Doi et al., 2009; Kim et al., 2010; Bock et al.,
2011). It was shown, for example, that iPSCs generated
from blood cells can be differentiated to blood cell
lineages with much greater efficiency than iPSCs derived
from fibroblasts (Kim et al., 2010). This problem may be
partially overcome by the addition of DNA demethylating
agents such as 5-azacytidine (Kim et al., 2010). Despite
global similarities between the DNA methylation profiles
of iPSCs and ESCs, several research groups identified
differentially methylated regions (DMRs) that could be
used to distinguish between these cell types. Bock et al.
(2011) showed that each of the ESC and iPSC lines analyzed
in their study could be characterized by a cell typespecific DNA methylation pattern that was stable during
subsequent cell divisions. The DNA methylation patterns
were more frequently variable among the iPSC than the
ESC lines. In another study, Ruiz et al. (2012) identified a
minimal reprogramming-associated epigenetic signature
that could be used to discriminate iPSCs from ESCs. This
signature comprised nine aberrantly methylated genes
whose methylation profiles were sustained even after
differentiation.
4.4. Genomic imprinting
Genomic imprinting is a regulatory mechanism that leads
to the preferential expression of a subset of genes either
from the maternal or paternal allele. This epigenetic
process involves changes in the DNA methylation pattern
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as well as histone modifications. Genomic imprinting
provides a mechanism for the dosage regulation of
genes with an essential role in embryonic growth and
development (Plasschaert and Bartolomei, 2014). Aberrant
imprinting of certain loci might initiate numerous
pathologies, including transient neonatal diabetes or
Beckwith–Wiedemann syndrome (Choufani et al., 2010;
Mackay and Temple, 2010; Plasschaert and Bartolomei,
2014). Imprinted loci are marked with methylated
cytosines in a uniparental fashion at the promoters of long
noncoding RNAs (lncRNAs), thereby providing cis-acting
transcriptional control of neighboring genes (Kanduri,
2016). The imprinting-associated methylation is removed
during the development of primordial germ cells. During
the course of gametogenesis, most of the DMRs adopt
their monoallelic methylation, which is preserved during
embryonic and somatic development. Interestingly, only
placental tissue acquires a different imprinting pattern
that includes sites frequently hypomethylated in germ cells
and ESCs (Court et al., 2014). Thus, faithful maintenance
of imprinting plays an important role in developmental
biology, and also in the reprogramming of somatic cells
into high-quality iPSCs. Because iPSCs may harbor
methylation aberrations, imprinting sites may undergo
hypo- or hypermethylation in some iPSC colonies (Hiura
et al., 2013; Takikawa et al., 2013). The most frequently cited
exception is the Dlk1-Dio3 cluster. Transcriptome analysis
of low grade-iPSCs compared to ESCs showed repressed
expression of the genes encoded by the Dlk1-Dio3 cluster
due to DNA hypermethylation. Downregulation of the
Dlk1-Dio3 cluster was also associated with a reduced ability
of iPSCs to form chimeras (Stadtfeld et al., 2010). This
phenotype could be reversed by the addition of vitamin C,
which prevented hypermethylation and thus silencing of
the Dlk1-Dio3 locus (Stadtfeld et al., 2012). The addition
of vitamin C to reprogramming media leads to the early
upregulation of the Dppa3 protein, which associates with
the Dlk1-Dio3 locus and antagonizes Dnmt3a binding,
thereby preventing Dnmt3a-mediated methylation within
this region (Xu et al., 2015).
4.5. X activation/inactivation
In mammals, X chromosome inactivation (XCI)
compensates for the dosage of X-linked gene expression
between sexes through the silencing of one of the two
X chromosomes in female cells. X reactivation in female
cells is one of the hallmark features of pluripotency. The
process occurs at the early stages of embryogenesis and as
one of the latest steps during iPSCs generation, whereas
differentiation induces XCI (Maherali et al., 2007; Stadtfeld
et al., 2008; Barakat et al., 2015). Several lncRNAs,
including Xist (X-inactive specific transcript) and Tsix
(antisense lncRNA repressor of Xist), participate in the
rearrangement of the X chromosome (Figure 3). Xist is
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transcribed from the inactivated X chromosome (Xi) and
interacts with Prc2. Prc2 recruited to the X chromosome
catalyzes the deposition of the repressive H3K27me3
mark and induces DNA methylation and macro-H2A
incorporation within the Xist-coated Xi (Jeon et al., 2012).
Pluripotency-related factors facilitate X inactivation. Oct4
was shown to regulate XCI through its direct interaction
with Tsix and other XCI factors, and its deficiency led
to the aberrant inactivation of both X chromosomes
(Donohoe et al., 2009). During reprogramming, female
iPSCs lose Xist expression and undergo X chromosome
reactivation (XCR) (Maherali et al., 2007; Pasque et al.,
2014). Upon XCR, stable Xi is converted to the active form
(Xa) by the erasure of the Xi-heterochromatin marks.
This event is observed late during reprograming after the
activation of endogenous pluripotency genes (Pasque et al.,
2014). Female mouse ESCs and iPSCs usually have both X
chromosomes active. However, human pluripotent stem
cells are highly heterogeneous in terms of their X status,
which supports the notion that mouse pluripotent stem
cells have a more naïve state in in vitro culture (Tchieu
et al., 2010; Tomoda et al., 2012). Nevertheless, culture
conditions and prolonged passaging of female iPSCs
contributes to XCR (Pasque et al., 2014).
5. Long noncoding RNAs (lncRNAs)
Long noncoding RNAs are endogenous RNAs longer
than 200 nucleotides. The molecular mode of action of
lncRNAs is exerted through various mechanisms that
are still insufficiently understood. Nevertheless, many
lncRNAs were shown to play a crucial role in the gene
expression control of the pluripotent and differentiated
states. These noncoding transcripts were shown to act as
scaffolds for chromatin remodeling complexes (e.g., Prc2),
competitors of endogenous miRNAs, or guides targeting
various molecules for degradation or to specific genomic/
transcriptomic sequences (Flynn and Chang, 2014). As
previously mentioned, lncRNAs participate in XCI (Jeon
et al., 2012) and in the cis-regulation of imprinted genes
(Kanduri, 2016), which are processes involved in normal
stem cell biology and development. The expression of
lncRNAs is tissue-type specific; thus, the induction of
pluripotency evokes massive changes in the expression
profile of lncRNAs (Kim et al., 2015). One of the
frequently upregulated transcripts in iPSCs is Regulator of
Reprogramming (lincRNA-RoR), which has been found to
be critical for the reprogramming of human fibroblasts. Its
upregulation improves and its downregulation hinders the
reprogramming efficiency (Loewer et al., 2010). Wang et
al. (2013) recently demonstrated that lncRNA-RoR acted
as a competing endogenous RNA (ceRNA) for a subset of
miRNAs (miR-145-5p, miR-181a-5p, and miR-99b-3p)
by targeting core pluripotency factors (Oct4, Sox2, and
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Figure 3. X chromosome inactivation and reactivation mechanisms. (A) During X chromosome inactivation (XCI), the
X-inactivation center (Xic) on one of the female X chromosomes triggers the transcription of the Xist lncRNA. Transcribed Xist
covers the X chromosome and recruits the Prc2 complex through RepA (repeat A transcript). Prc2 catalyzes the deposition of the
repressive H3K27me3 mark that strengthens X chromosome inactivation. (B) X chromosome reactivation (XCR) occurs during the
early stages of embryogenesis and during induction to pluripotency. The Xist antisense transcript lncRNA Tsix competitively binds
to Prc2, thereby abolishing the interaction between Xist and Prc2 and inducing X chromosome reactivation.

Nanog) to prevent their miRNA-mediated decay. LincRoR creates a feedback loop with specific miRNAs and
pluripotency-related transcription factors to govern stem
cell identity. Downregulation of lncRNA-RoR reduced the
self-renewal properties of ESCs, whereas overexpression
sustained the high expression of pluripotency factors and
the undifferentiated state in ESCs cultured without FGF.
6. miRNAs
MiRNAs are short, noncoding, 18–25-nucleotide RNAs
that regulate gene expression in a sequence-specific
manner via directing RISC (RNA-induced silencing
complex) to degradation-targeted mRNAs. These tiny
molecules play an enormous role in the posttranscriptional
gene regulation of many pathways, including the pathways
involved in pluripotency, self-renewal, and differentiation.
Pluripotency-promoting miRNAs repress differentiation
signals, whereas differentiation-promoting miRNAs
suppress the pluripotency regulation network and
reinforce differentiation and lineage commitment (Li
and He, 2012). Profiling of miRNA expression revealed

a signature that was characteristic for the ESC state that
included the upregulated miR-290/295, miR-17/92, and
miR-302/367 clusters and downregulation of the let-7
family, miR-210, and miR-145 (Melton et al., 2010; Li and
He, 2012; Gao et al., 2015; Sen and Ghatak, 2015). MiRNA
clusters belonging to the miR-290/295, miR-302a/367, and
miR17/92 families function as cell cycle moderators and
are known to be embryonic stem cell-specific cell cycleregulating miRNAs (ESCCs) (Li and He, 2012). In ESCs,
the miR290/295 cluster targets cell cycle inhibitors (e.g.,
the Wnt pathway inhibitor Dkk1), resulting in increased
ESC proliferation due to the promoted transition from
the G to S1 phase (Wang et al., 2008; Zovoilis et al., 2009).
Moreover, this family (and specifically miR-294) was
shown to improve the reprogramming efficiency of the
OSK cocktail compared to OSK alone to a level similar to
the OSKM-induced reprogramming by partial substitution
of the c-Myc function (Judson et al., 2009). Similar effects
in enhanced reprogramming by replacing c-Myc were
obtained with the ectopic expression of miR-93, miR-106b,
and the miR-302a/367 cluster (Anokye-Danso et al., 2011;
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Li et al., 2011; Subramanyam et al., 2011). Interestingly, core
pluripotency transcription factors bind to the promoter of
the miR-290 cluster and induce its expression. The miR-290
cluster also acts as a functional antagonist of let-7 (known
to be an inducer of differentiation) via the upregulation of
Lin28, which is an RNA-binding protein that hinders the
maturation of let-7 (Melton et al., 2010). Moreover, Gao et al.
(2015) reported that the addition of vitamin C upregulated
the expression of ESCC miRNAs and maintained their
pluripotency-specific miRNA expression patterns.
7. Summary and future perspectives
The last few years have provided mounting evidence
for the involvement of the epigenetic machinery in
the maintenance of pluripotency, differentiation, and
reprogramming of somatic cells into iPSCs. Pluripotent stem
cells contain an open chromatin structure with multiple
activating modifications. This type of architecture needs
to be reestablished during reprogramming to enable the
generation of high-quality iPSCs. The field exploring stem
cell biology is still expanding, and many processes involved
in stemness regulation need to be further investigated.
The majority of studies have tested how a single or a small
subset of epigenetic modifiers influences stem cell behavior.

Moreover, a number of cellular transcription factors,
signaling molecules, and metabolites were shown to affect
epigenetic states. Nevertheless, the communication between
these cellular entities has been insufficiently defined. With
the growing accessibility to high-throughput and single
cell assays, it will be possible to integrate various molecular
profiles (e.g., DNA methylation, histone modifications,
RNA and protein expression, metabolites) of cells at various
developmental stages. This systematic approach will help
to elucidate the exact interactions between epigenetic
modifiers and other cellular factors implicated in the cell
fate transition and the kinetics of developmental shifts. An
improved understanding of the spatiotemporal molecular
alterations driving differentiation and dedifferentiation
will provide novel tools for the conscious manipulation of
these cells and new insights into the pathological events
associated with disordered development.
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